Literature DB >> 31243460

A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases.

Yi Xuan Lee1, Yu Heng Kwan2, Ka Keat Lim2, Chuen Seng Tan3, Nai Lee Lui4, Jie Kie Phang4, Eng Hui Chew1, Truls Ostbye2, Julian Thumboo4, Warren Fong4.   

Abstract

This was a systematic review of the literature on the association between obesity and the outcome of inflammatory rheumatic diseases. We conducted a literature search using PubMed®, Embase and PsycINFO®. Articles were classified into three categories based on the effects of obesity on the outcomes of inflammatory rheumatic diseases. The subject population, country, type of studies, number of patients, measurement of obesity and outcomes assessed were presented. Quality was appraised using Kmet et al's criteria. 4,331 articles were screened and 60 were relevant to the objective. Obesity had a negative, positive and neutral association with outcomes of inflammatory rheumatic diseases in 38 (63.3%) studies with 57,612 subjects, 11 (18.3%) studies with 3,866 subjects, and 11 (18.3%) studies with 3,834 subjects, respectively. In most studies, the disease population had been diagnosed with rheumatoid arthritis (RA). Tumour necrosis factor-α inhibitors were mostly associated with negative outcomes. More studies examining subjects outside Europe and North America and diseases other than RA are warranted. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  association; obesity; outcomes; rheumatology

Mesh:

Year:  2019        PMID: 31243460      PMCID: PMC6595055          DOI: 10.11622/smedj.2019057

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  71 in total

1.  Impact of obesity on functioning among women with systemic lupus erythematosus.

Authors:  Patricia Katz; Jinoos Yazdany; Laura Julian; Laura Trupin; Mary Margaretten; Edward Yelin; Lindsey A Criswell
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-10       Impact factor: 4.794

2.  Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine.

Authors:  Elisa Gremese; Antonio Carletto; Melissa Padovan; Fabiola Atzeni; Bernd Raffeiner; Anna Rita Giardina; Ennio Giulio Favalli; Gian Luca Erre; Roberto Gorla; Mauro Galeazzi; Rosario Foti; Fabrizio Cantini; Carlo Salvarani; Ignazio Olivieri; Giovanni Lapadula; Gianfranco Ferraccioli
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

3.  Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.

Authors:  D Jawaheer; J Olsen; M Lahiff; S Forsberg; J Lähteenmäki; I G da Silveira; F A Rocha; I M Magalhães Laurindo; L M Henrique da Mota; A A Drosos; E Murphy; C Sheehy; E Quirke; M Cutolo; S Rexhepi; J Dadoniene; S M M Verstappen; T Sokka
Journal:  Clin Exp Rheumatol       Date:  2010-08-30       Impact factor: 4.473

4.  Prevalence of overweight in Moroccan patients with rheumatoid arthritis and its relationships with disease features.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Fahd Wafki; Fatima Znat; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2011-10-27       Impact factor: 2.980

5.  Waist circumference based abdominal obesity may be helpful as a marker for unmet needs in patients with RA.

Authors:  T Uutela; H Kautiainen; S Järvenpää; S Salomaa; M Hakala; A Häkkinen
Journal:  Scand J Rheumatol       Date:  2014-01-27       Impact factor: 3.641

6.  Relation between body mass index and radiological progression in patients with rheumatoid arthritis.

Authors:  Jörg Kaufmann; Volker Kielstein; Susann Kilian; Günter Stein; Gert Hein
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

7.  Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index.

Authors:  Gisela Westhoff; Rolf Rau; Angela Zink
Journal:  Arthritis Rheum       Date:  2007-11

8.  Association of body fat with C-reactive protein in rheumatoid arthritis.

Authors:  Jon T Giles; Susan J Bartlett; Ross Andersen; Richard Thompson; Kevin R Fontaine; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2008-09

9.  Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.

Authors:  Joshua F Baker; Mikkel Ostergaard; Michael George; Justine Shults; Paul Emery; Daniel G Baker; Philip G Conaghan
Journal:  Ann Rheum Dis       Date:  2014-08-04       Impact factor: 19.103

10.  Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.

Authors:  Raphael Micheroli; Monika Hebeisen; Lukas M Wildi; Pascale Exer; Giorgio Tamborrini; Jürg Bernhard; Burkhard Möller; Pascal Zufferey; Michael J Nissen; Almut Scherer; Adrian Ciurea
Journal:  Arthritis Res Ther       Date:  2017-07-19       Impact factor: 5.156

View more
  4 in total

1.  Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis.

Authors:  Jean W Liew; Irvin J Huang; Diana N Louden; Namrata Singh; Lianne S Gensler
Journal:  RMD Open       Date:  2020-05

2.  Culturing Articular Cartilage Explants in the Presence of Autologous Adipose Tissue Modifies Their Inflammatory Response to Lipopolysaccharide.

Authors:  Wendy Pearson; Anna E N Garland; Ashley Nixon; John P Cant; Mark B Hurtig
Journal:  Mediators Inflamm       Date:  2020-11-12       Impact factor: 4.711

3.  Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial.

Authors:  Sook Yan Lee; Fowzia Ibrahim; Brian D M Tom; Elena Nikiphorou; Frances M K Williams; Heidi Lempp; David L Scott
Journal:  Arthritis Res Ther       Date:  2021-11-04       Impact factor: 5.156

4.  Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort.

Authors:  Enriqueta Vallejo-Yagüe; Theresa Burkard; Raphael Micheroli; Andrea Michelle Burden
Journal:  BMJ Open       Date:  2022-09-17       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.